Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave.

MLA

Beilhack, Georg, et al. “Durable Anti-SARS-CoV-2 Antibody Response after MRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave.” Vaccines, vol. 11, no. 6, June 2023, p. 1121. EBSCOhost, https://doi.org/10.3390/vaccines11061121.

APA

Beilhack, G., Monteforte, R., Frommlet, F., Reindl-Schwaighofer, R., Strassl, R., & Vychytil, A. (2023). Durable Anti-SARS-CoV-2 Antibody Response after mRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave. Vaccines, 11(6), 1121. https://doi.org/10.3390/vaccines11061121

Chicago

Beilhack, Georg, Rossella Monteforte, Florian Frommlet, Roman Reindl-Schwaighofer, Robert Strassl, and Andreas Vychytil. 2023. “Durable Anti-SARS-CoV-2 Antibody Response after MRNA-1273 Booster in Peritoneal Dialysis Patients during the Omicron Wave.” Vaccines 11 (6): 1121. doi:10.3390/vaccines11061121.